Home › Valeant Pharma projects double-digit growth in sales, earnings per share in 2015
 

Keywords :   


Valeant Pharma projects double-digit growth in sales, earnings per share in 2015

2015-01-08 17:21:17| Biotech - Topix.net

Valeant Pharmaceuticals International Inc. says it plans to focus on small to medium-sized acquisitions from privately owned companies in 2015 following an unsuccessful attempt to take over California-based Allergan. The Quebec-based company told analysts that it believes its blockbuster bid for the maker of Botox would have been successful if a higher bid hadn't emerged from Actavis, which agreed to pay US$66 billion in cash and stock.

Tags: share sales growth projects

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Graphics
02.11Tropical Storm Lane Wind Speed Probabilities Number 5
02.11Tropical Storm Lane Forecast Advisory Number 5
02.11Tropical Storm Lane Public Advisory Number 5
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Forecast Discussion Number 3
02.11Subtropical Storm Patty Wind Speed Probabilities Number 3
More »